ff-10101-01: a novel flt3 inhibitor for r/r aml
Published 3 years ago • 141 plays • Length 3:04Download video MP4
Download video MP3
Similar videos
-
3:27
novel flt3 inhibitors for aml
-
1:30
a phase i trial investigating a novel oral flt3 inhibitor, bmf-500, in flt3-mutant aml
-
1:32
novel treatment combinations for flt3-mutated aml
-
1:12
the value of flt3 inhibitors in aml and focus for future trial designs
-
2:44
phase i/ii study of novel flt3 inhibitor hm43239 in r/r aml
-
1:09
menin inhibitors for the treatment of aml: insights into the covalent-101 trial
-
11:06
how could new treatment options improve outcomes in flt3-mutated aml?
-
7:46
updates in aml treatment and research from asco 2023
-
10:23
my acute myeloid leukemia (aml) relapse story
-
2:29
flt3 inhibitors as maintenance therapy in aml
-
2:19
novel potent and selective flt3 inhibitors
-
2:15
novel agents in trials for aml: quizartinib and gilteritinib
-
2:35
quizartinib for frontline flt3-itd aml: updated results from the quantum-first trial
-
2:26
improving outcomes for flt3-mutated r/r aml
-
2:40
an overview of the safety profile of flt3 inhibitors in aml
-
1:58
efficacy of first generation flt3 inhibitors for aml
-
1:24
mechanisms of resistance to flt3 inhibitors in aml and strategies to overcome this
-
1:40
sf3b1 as therapeutic target in flt3/itd positive aml
-
1:40
second-generation flt3 inhibitors in the treatment of flt3-itd aml
-
1:20
flt3 inhibitors as mrd-guided salvage treatment for molecular failure in flt3-mutated aml
-
1:56
promising targets beyond flt3 in aml: idh1/2 & menin
-
1:59
optimizing the use of flt3 inhibitors in aml: sequencing, post-transplant maintenance & more